Jynneos isn't expected to be a seasonal vaccine like flu shots, but Kimak said the company expects some spikes in demand prior to pride events. Bavarian Nordic has partnered with organizations ...

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS ...

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS ...

Bavarian Nordic A/S, a fully integrated vaccine company, announced that Jynneos, the only FDA-approved mpox vaccine, is now commercially available in the US, marking a significant expansion for access ...

COPENHAGEN, Denmark, April 2, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today that JYNNEOS ®, the only FDA-approved mpox vaccine, is now commercially available in the U.S., marking a ...

(Image Credits: AP) Bavarian Nordic A/S, a fully integrated vaccine company, on Tuesday announced that Jynneos, the only FDA-approved mpox vaccine, is now commercially available in the United States.

Credit: Bavarian Nordic. The commercial launch of Jynneos allows health care providers to order the vaccine and make it available to patients in physician offices and pharmacies, in addition to ...

COPENHAGEN, Denmark, April 2, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today that JYNNEOS®, the only FDA-approved mpox vaccine, is now commercially available in the U.S., marking a significant ...